PERKINS CAPITAL MANAGEMENT INC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 5.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
PERKINS CAPITAL MANAGEMENT INC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$30
-74.1%
13,700
-70.0%
0.03%
-76.1%
Q1 2023$116
+36.5%
45,7000.0%0.11%
+21.1%
Q4 2022$85
-99.9%
45,700
-8.0%
0.09%
-37.1%
Q3 2022$128,000
+33.3%
49,7000.0%0.14%
+44.4%
Q2 2022$96,000
-35.1%
49,7000.0%0.10%
-18.2%
Q1 2022$148,000
-45.2%
49,700
-17.4%
0.12%
-33.5%
Q4 2021$270,000
-27.0%
60,200
-21.0%
0.18%
-20.5%
Q3 2021$370,000
-28.8%
76,2000.0%0.23%
-22.4%
Q2 2021$520,000
-3.0%
76,200
+0.5%
0.30%
-4.8%
Q1 2021$536,00075,8500.31%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,339,107$10,502,0003.20%
Telemetry Investments, L.L.C. 262,279$1,178,0001.52%
Bruce & Co., Inc. 1,443,312$6,480,0001.30%
Omega Fund Management, LLC 1,971,241$8,851,0001.25%
Worth Venture Partners, LLC 556,832$2,500,0001.24%
Abingworth LLP 1,041,131$4,654,0001.13%
1492 Capital Management LLC 491,033$2,205,0001.09%
CM Management, LLC 300,000$1,347,0001.02%
Trellus Management Company, LLC 295,000$1,325,0000.88%
GENERAL AMERICAN INVESTORS CO INC 1,306,919$5,868,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders